60 related articles for article (PubMed ID: 30957411)
1. Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma.
Tang M; Zhang S; Yang M; Feng R; Lin J; Chen X; Xu Y; Yu R; Liao X; Li Z; Li X; Li M; Zhang Q; Chen S; Qian W; Liu Y; Song L; Li J
Clin Cancer Res; 2024 May; 30(10):2206-2224. PubMed ID: 38470497
[TBL] [Abstract][Full Text] [Related]
2. LAGE3 promotes angiogenesis on hepatocellular carcinoma by stabilizing VEGFA mRNA.
Cong Z; Zhao H; Zhang S; You T; Xie Y
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167196. PubMed ID: 38653358
[TBL] [Abstract][Full Text] [Related]
3. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
[TBL] [Abstract][Full Text] [Related]
4. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.
Yang B; Li M; Tang W; Liu W; Zhang S; Chen L; Xia J
Nat Commun; 2018 Feb; 9(1):678. PubMed ID: 29445139
[TBL] [Abstract][Full Text] [Related]
5. The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs).
Amal H; Ding L; Liu BB; Tisch U; Xu ZQ; Shi DY; Zhao Y; Chen J; Sun RX; Liu H; Ye SL; Tang ZY; Haick H
Int J Nanomedicine; 2012; 7():4135-46. PubMed ID: 22888249
[TBL] [Abstract][Full Text] [Related]
6. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
7. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
Mao X; Zhou L; Tey SK; Ma APY; Yeung CLS; Ng TH; Wong SWK; Liu BHM; Fung YME; Patz EF; Cao P; Gao Y; Yam JWP
J Extracell Vesicles; 2020 Nov; 10(1):e12031. PubMed ID: 33708358
[TBL] [Abstract][Full Text] [Related]
8. Tripartite motif containing 69 elicits ERK2-dependent EYA4 turnover to impart pancreatic tumorigenesis.
Jia Y; Li HY; Wang J; Chen X; Lou L; Wei YY; Wang Y; Mo SJ
J Cancer; 2023; 14(2):200-218. PubMed ID: 36741265
[TBL] [Abstract][Full Text] [Related]
9. Novel Methylation Biomarkers for Colorectal Cancer Prognosis.
Gutierrez A; Demond H; Brebi P; Ili CG
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827720
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
11. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
12. Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP
Eur J Cancer; 2007 Apr; 43(6):979-92. PubMed ID: 17291746
[TBL] [Abstract][Full Text] [Related]
13. The Role of Endoglin in Hepatocellular Carcinoma.
Jeng KS; Sheen IS; Lin SS; Leu CM; Chang CF
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809908
[TBL] [Abstract][Full Text] [Related]
14. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
[TBL] [Abstract][Full Text] [Related]
15. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
